Lexaria Bioscience Corp
Biotechnology
Healthcare
LEXX
17.51 M shares
NASDAQ US
traded
22 Sep 2025
listed
no
open
1.24
52 week high
4.09
high
1.35
52 week low
0.00
low
1.20
growth
-58.59 %
previous Close
1.46
P/E ratio
market cap
17.60 M
div yield
0
usd
May 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
1559.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top